Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03589222
Recruitment Status : Recruiting
First Posted : July 17, 2018
Last Update Posted : July 27, 2018
Sponsor:
Information provided by (Responsible Party):
PETHEMA Foundation

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : June 2022